Indivior PLC
Pharmaceutical company developing medicines for substance use and mental disorders.
INDV | IL
Overview
Corporate Details
- ISIN(s):
- GB00BN4HT335 (+2 more)
- LEI:
- 213800V3NCQTY7IED471
- Country:
- United Kingdom
- Address:
- 234 BATH ROAD, SL1 4EE SLOUGH
- Website:
- https://www.indivior.com/en
- Sector:
- Manufacturing
Description
Indivior PLC is a global pharmaceutical company that develops, manufactures, and sells medicines to treat substance use disorders (SUD) and serious mental illnesses. The company's primary focus is on pioneering treatments for opioid use disorder (OUD), with a portfolio centered on buprenorphine-based prescription pharmaceuticals. Through its research and development efforts, Indivior aims to address the complex challenges of addiction and behavioral health by providing innovative, life-transforming therapies for patients worldwide.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2017-12-12 08:00 |
Indivior's RBP-7000 NDA Accepted by FDA
|
English | 20.4 KB | ||
| 2017-12-08 08:00 |
Additional Listing
|
English | 8.1 KB | ||
| 2017-12-01 08:00 |
FDA Approves SUBLOCADE (TM)
|
English | 81.3 KB | ||
| 2017-11-23 14:46 |
Holding(s) in Company
|
English | 61.9 KB | ||
| 2017-11-10 17:02 |
Block listing Interim Review
|
English | 23.7 KB | ||
| 2017-11-06 08:00 |
Jefferies London Healthcare Conference
|
English | 11.9 KB | ||
| 2017-11-02 14:28 |
Board Committee Changes
|
English | 9.0 KB | ||
| 2017-11-02 12:40 |
Holding(s) in Company
|
English | 61.9 KB | ||
| 2017-11-02 12:00 |
3rd Quarter Results
|
English | 352.6 KB | ||
| 2017-11-01 08:00 |
FDA Advisory Committees Vote to Approve RBP-6000
|
English | 18.9 KB | ||
| 2017-10-10 09:00 |
Notice of Results
|
English | 12.1 KB | ||
| 2017-10-09 15:17 |
Holding(s) in Company
|
English | 66.4 KB | ||
| 2017-10-03 18:00 |
FDA Posts Advisory Committee Notice for RBP-6000
|
English | 15.4 KB | ||
| 2017-10-02 09:00 |
RBP-7000 - Submission of NDA to U.S. FDA
|
English | 21.9 KB | ||
| 2017-09-25 09:00 |
Indivior settlement with Mylan Pharmaceuticals
|
English | 25.6 KB |
Automate Your Workflow. Get a real-time feed of all Indivior PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Indivior PLC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Indivior PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
